صفحه 1 از جانب 17 نتایج
FIELD OF THE INVENTION
The present invention relates to certain compounds having cytoprotective activity, and particularly to a series of benzofuran derivatives. The invention is also directed to formulations and methods for treating stroke, myocardial infarction and chronic heart failure, as well
The present invention relates, in general, to the use of antiarrhythmic compounds for the prevention of mortality following myocardial infarction.
In particular, the subject of the invention is the use of benzofuran derivatives known for their antiarrhythmic activity, in particular amiodarone, or of
This application is a 371 of PCT/JP92/00875 filed Jul. 8, 1992.
TECHNICAL FIELD
The present invention relates to a novel benzofuran derivative, expressed by the following general formula (I) and pharmacologically-acceptable salt thereof, which exhibits a therapeutic action for diseases caused by
The invention relates to substituted benzofuran-2-carboxamides of the formula I
##STR00002## in which D is H, OH, OA, CN, Hal, COR.sup.3 or CH.sub.2R.sup.3, R.sup.1 is amino, hydroxyl, cyano, --C(.dbd.NR.sup.4)--N(R.sup.4).sub.2, Het, unsubstituted or A-substituted cycloalkyl having from 3 to 10
FIELD OF THE INVENTION
The present invention relates to novel compounds, to processes for preparing them and to their use in treating medical disorders.
BACKGROUND OF THE INVENTION
1-[4-(5-Cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine- , its physiologically acceptable salts
FIELD OF THE INVENTION
The present invention relates to novel compounds, to processes for preparing them and to their use in treating medical disorders.
BACKGROUND OF THE INVENTION
1-[4-(5-Cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine- , its physiologically acceptable salts
FIELD OF THE INVENTION
The present invention relates to novel compounds, to processes for preparing them and to their use in treating medical disorders.
BACKGROUND OF THE INVENTION
1-[4-(5-Cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine- , its physiologically acceptable salts
FIELD OF THE INVENTION
The present invention relates to novel compounds, to processes for preparing them and to their use in treating medical disorders.
BACKGROUND OF THE INVENTION
1-[4-(5-Cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine- , its physiologically acceptable salts
FIELD OF THE INVENTION
The present invention relates to novel compounds, to processes for preparing them and to their use in treating medical disorders.
BACKGROUND OF THE INVENTION
1-[4-(5-Cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine- , its physiologically acceptable salts
FIELD OF THE INVENTION
The present invention relates to novel compounds, to processes for preparing them and to their use in treating medical disorders.
BACKGROUND OF THE INVENTION
1-[4-(5-Cyanoindol-3-yl)butyl]4-(2-carbamoyl-benzofuran-5-yl)-piperazine, its physiologically acceptable salts thereof
FIELD OF THE INVENTION
The present invention relates to novel compounds, to processes for preparing them and to their use in treating medical disorders.
BACKGROUND OF THE INVENTION
1-[4-(5-Cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine- , its physiologically acceptable salts
FIELD OF THE INVENTION
The present invention relates to novel compounds, to processes for preparing them and to their use in treating medical disorders.
BACKGROUND OF THE INVENTION
1-[4-(5-Cyanoindol-3-yl)butyl]-4-(2-carbamoyl -benzofuran-5-yl)-piperazine, its physiologically acceptable salts
FIELD OF THE INVENTION
The present invention relates to novel compounds, to processes for preparing them and to their use in treating medical disorders.
BACKGROUND OF THE INVENTION
1-[4-(5-Cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine- , its physiologically acceptable salts
FIELD OF THE INVENTION
The present invention relates to novel compounds, to processes for preparing them and to their use in treating medical disorders.
BACKGROUND OF THE INVENTION
1-[4-(5-Cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine- , its physiologically acceptable salts
This application is a 371 of PCT/JP93/01489 filed Oct. 18, 1993 and published as WO94/08930 Apr. 28, 1994.
TECHNICAL FIELD
This invention relates to compounds for preventing the oxidative modification of LDL, particularly, to compounds useful as therapeutics of arteriosclerosis, myocardial